The QMN Weekly Bulletin
Quality / Medical Devices / Regulatory Affairs / Inspections and Audits

St. Jude Makes Progress on Warning, Sees CRM Growth in Fourth Quarter

March 7, 2014
St. Jude’s Sylmar, Calif., plant, which makes most of its CRM products, should soon emerge from an FDA warning letter, CEO Dan Starks said on the company’s earnings call last month.
The GMP Letter